KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ardelyx (ARDX) Research & Development (2016 - 2026)

Ardelyx (ARDX) has disclosed Research & Development for 14 consecutive years, with $20.2 million as the latest value for Q1 2026.

  • For Q1 2026, Research & Development rose 35.15% year-over-year to $20.2 million; the TTM value through Mar 2026 reached $76.8 million, up 35.47%, while the annual FY2025 figure was $71.5 million, 36.72% up from the prior year.
  • Research & Development hit $20.2 million in Q1 2026 for Ardelyx, down from $22.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $22.9 million in Q4 2025 and bottomed at $7.5 million in Q3 2022.
  • Average Research & Development over 5 years is $12.6 million, with a median of $10.6 million recorded in 2024.
  • Year-over-year, Research & Development tumbled 68.49% in 2022 and then soared 77.26% in 2024.
  • Ardelyx's Research & Development stood at $9.1 million in 2022, then increased by 4.18% to $9.5 million in 2023, then surged by 43.49% to $13.7 million in 2024, then soared by 67.25% to $22.9 million in 2025, then dropped by 11.67% to $20.2 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $20.2 million, $22.9 million, and $18.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.